Skip to main content

Table 1 Baseline clinical characteristics of participants from GHS (N = 356)

From: Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes

Males (%) 67.4
Age (years) 64.5 ± 8.2
Smokers (%) 63 (17.7)
BMI (kg/m2) 30.2 ± 4.8
HbA1C (%) 8.6 ± 1.9
Total cholesterol (mg/dl) 176.0 ± 45.8
HDL-cholesterol (mg/dl) 43.6 ± 14.6
Tryglicerides (mg/dl) 152.3 ± 91.8
Insulin w/wh oral agents (%) 192 (54.0)
Hypertension (%) 302 (84.8)
HMW-adiponectin (µg/ml) 3.1 ± 2.5
Total adiponectin (µg/ml) 4.9 ± 2.9
  1. Continuous variables were reported as mean ± SD whereas categorical variables as total frequency and percentages
  2. GHS Gargano heart study, BMI body mass index, HbA1c glycated haemoglobin A1c HDL-cholesterol high density lipoprotein-cholesterol, HMW-adiponectin high molecular weight-adiponectin